Health Care: Drugs

Alnylam Pharmaceuticals Inc (ALNY: NASDAQ)

$81.01 -2.53 | -3.03%
07/25/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 83.54
52 Week High 86.92
52 Week Low 31.38
Avg. Daily Vol. (Mil) 1.13
Beta (3 year) 3.46
Share Related Items
Mkt Cap (Mil) 7,200.33
Shares Out (Mil) 86.19
Float (Mil) 40.80
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.00
Current Ratio 6.20
LT Debt/ Equity 0.18
Total Debt / Equity 0.18
Valuation Ratios
Price Earnings n.a.
Price/Sales 122.51
Price/Book 8.67
Price/Cash Flow -18.00
Per Share Data
Earnings -4.82
Sales 0.68
Book Value 9.64
Cash Flow -4.65
Business Summary
Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
General Information
300 Third Street
Cambridge, MA 02142
Industry : Drugs
Sector: Health Care
Employees: 514
CEO: Dr. John M. Maraganore,PhD
Short Interest
Current Month (Mil) 8.90
Previous Month (Mil) 9.88
Short Interest Ratio (Days) 8.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -36.50
Return on Investments -42.20
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ALNY

Latest ALNY Headlines from TheStreet

More Financial News for ALNY

Press Releases for ALNY

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter